GLAUKOS Corp (GKOS) Operating Margin
- Operating margin · 12 months: Value -31.55%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -31.55% | Operating income / revenue. Period ending 2026-06-30. $-193.36M ÷ $612.84M × 100 ≈ -31.55% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -193.36M USD | Operating Income (Loss) |
| Revenue | 612.84M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 127.96M USD | Cost of Goods and Services Sold |
| Research and development | (m) | Research and Development Expense |
| Selling, general and administration | 386.70M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-193.36M | $612.84M | $127.96M | (m) | $386.70M | -31.55% |
| 2026-03-31 | $-198.78M | $551.35M | $120.84M | (m) | $354.02M | -36.05% |
| 2025-12-31 | $-199.60M | $507.44M | $111.81M | (m) | $331.75M | -39.33% |
| 2025-09-30 | $-88.40M | $469.82M | $108.68M | (m) | $306.05M | -18.82% |
| 2025-06-30 | $-96.69M | $432.95M | $102.43M | (m) | $287.05M | -22.33% |
| 2025-03-31 | $-103.98M | $404.52M | $98.08M | (m) | $269.86M | -25.70% |
| 2024-12-31 | $-122.37M | $383.48M | $94.03M | (m) | $261.17M | -31.91% |
| 2024-09-30 | $-132.32M | $360.35M | $84.28M | (m) | $255.20M | -36.72% |
| 2024-06-30 | $-135.67M | $341.73M | $80.21M | (m) | $245.44M | -39.70% |
| 2024-03-31 | $-134.77M | $326.43M | $77.76M | (m) | $232.39M | -41.29% |
| 2023-12-31 | $-128.70M | $314.71M | $75.58M | (m) | $224.07M | -40.89% |
| 2023-09-30 | $-123.81M | $303.57M | $73.91M | (m) | $212.96M | -40.78% |
| 2023-06-30 | $-117.41M | $296.79M | $72.26M | (m) | $205.86M | -39.56% |
| 2023-03-31 | $-125.10M | $289.08M | $69.99M | (m) | $202.63M | -43.27% |
| 2022-12-31 | $-82.31M | $282.86M | $68.98M | (m) | $192.93M | -29.10% |
| 2022-09-30 | $-66.45M | $284.88M | $68.62M | (m) | $188.56M | -23.33% |
| 2022-06-30 | $-33.81M | $288.32M | $67.13M | (m) | $185.88M | -11.73% |
| 2022-03-31 | $-11.28M | $293.72M | $67.06M | (m) | $181.28M | -3.84% |
| 2021-12-31 | $-32.87M | $294.01M | $66.63M | (m) | $179.26M | -11.18% |
| 2021-09-30 | $-26.39M | $294.00M | $69.35M | (m) | $175.48M | -8.98% |
| 2021-06-30 | $-49.77M | $284.13M | $71.91M | (m) | $169.96M | -17.52% |
| 2021-03-31 | $-82.75M | $237.59M | $75.82M | (m) | $162.78M | -34.83% |
| 2020-12-31 | $-123.55M | $224.96M | $91.72M | (m) | $171.40M | -54.92% |
| 2020-09-30 | $-141.86M | $217.57M | $88.03M | (m) | $187.22M | -65.20% |
| 2020-06-30 | $-141.92M | $211.25M | $77.80M | (m) | $192.72M | -67.18% |
| 2020-03-31 | $-100.96M | $238.29M | $64.01M | (m) | $192.26M | -42.37% |
| 2019-12-31 | $-50.29M | $236.98M | $38.59M | (m) | $176.63M | -21.22% |
| 2019-09-30 | $-18.70M | $225.21M | $29.80M | (m) | $149.13M | -8.30% |
| 2019-06-30 | $-13.22M | $210.61M | $28.11M | (m) | $136.32M | -6.28% |
| 2019-03-31 | $-11.23M | $195.17M | $26.40M | $52.70M | $127.30M | -5.75% |
| 2018-12-31 | $-13.00M | $181.28M | $25.07M | $49.68M | $119.53M | -7.17% |
| 2018-09-30 | $-14.37M | $168.85M | (m) | (m) | $113.39M | -8.51% |
| 2018-06-30 | $-6.68M | $165.36M | (m) | (m) | $105.90M | -4.04% |
| 2018-03-31 | $-6.30M | $163.48M | (m) | (m) | $101.93M | -3.85% |
| 2017-12-31 | $-2.28M | $159.25M | (m) | $38.91M | $96.26M | -1.43% |
| 2017-09-30 | $-2.35M | $150.78M | (m) | (m) | $90.79M | -1.56% |
| 2017-06-30 | $-2.06M | $139.94M | (m) | (m) | $83.50M | -1.47% |
| 2017-03-31 | $3.92M | $127.21M | (m) | $31.10M | $73.95M | 3.08% |
| 2016-12-31 | $4.24M | $114.40M | (m) | $29.22M | $64.76M | 3.71% |
| 2016-09-30 | $1.77M | $101.50M | (m) | $28.12M | $56.65M | 1.74% |
| 2016-06-30 | $-987.00K | $90.93M | (m) | $26.48M | $51.04M | -1.09% |
| 2016-03-31 | $-8.49M | $80.13M | (m) | $26.87M | $48.43M | -10.60% |
| 2015-12-31 | $-10.30M | $71.70M | (m) | $25.05M | $43.96M | -14.36% |
| 2015-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | $-10.33M | (m) | (m) | $20.06M | $30.00M | (m) |
| 2014-12-31 | $-13.17M | $45.59M | (m) | $19.20M | $28.14M | -28.89% |
| 2014-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $-14.20M | $20.95M | (m) | $15.51M | $17.10M | -67.78% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |